Literature DB >> 11018013

Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.

P Komarnitsky1, E J Cho, S Buratowski.   

Abstract

The activities of several mRNA processing factors are coupled to transcription through binding to RNA polymerase II (Pol II). The largest subunit of Pol II contains a repetitive carboxy-terminal domain (CTD) that becomes highly phosphorylated during transcription. mRNA-capping enzyme binds only to phosphorylated CTD, whereas other processing factors may bind to both phosphorylated and unphosphorylated forms. Capping occurs soon after transcription initiation and before other processing events, raising the question of whether capping components remain associated with the transcription complex after they have modified the 5' end of the mRNA. Chromatin immunoprecipitation in Saccharomyces cerevisiae shows that capping enzyme cross-links to promoters but not coding regions. In contrast, the mRNA cap methyltransferase and the Hrp1/CFIB polyadenylation factor cross-link to both promoter and coding regions. Remarkably, the phosphorylation pattern of the CTD changes during transcription. Ser 5 phosphorylation is detected primarily at promoter regions dependent on TFIIH. In contrast, Ser 2 phosphorylation is seen only in coding regions. These results suggest a dynamic association of mRNA processing factors with differently modified forms of the polymerase throughout the transcription cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018013      PMCID: PMC316976          DOI: 10.1101/gad.824700

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  38 in total

1.  RNA polymerase II is an essential mRNA polyadenylation factor.

Authors:  Y Hirose; J L Manley
Journal:  Nature       Date:  1998-09-03       Impact factor: 49.962

2.  Analysis of chromatin structure by in vivo formaldehyde cross-linking.

Authors:  V Orlando; H Strutt; R Paro
Journal:  Methods       Date:  1997-02       Impact factor: 3.608

Review 3.  Messenger RNA capping enzymes from eukaryotic cells.

Authors:  K Mizumoto; Y Kaziro
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1987

Review 4.  Capping enzyme in eukaryotic mRNA synthesis.

Authors:  S Shuman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

5.  A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription.

Authors:  T P Mäkelä; J D Parvin; J Kim; L J Huber; P A Sharp; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes.

Authors:  E B Rasmussen; J T Lis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 7.  The role of multisite phosphorylation in the regulation of RNA polymerase II activity.

Authors:  M E Dahmus
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

8.  Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription.

Authors:  H Serizawa; J W Conaway; R C Conaway
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

9.  Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing.

Authors:  J R Weeks; S E Hardin; J Shen; J M Lee; A L Greenleaf
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

10.  Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains.

Authors:  D B Bregman; L Du; S van der Zee; S L Warren
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  521 in total

1.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.

Authors:  N Fong; D L Bentley
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

2.  Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain.

Authors:  E J Cho; M S Kobor; M Kim; J Greenblatt; S Buratowski
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Old dogs and new tricks: meeting on mechanisms of eukaryotic transcription.

Authors:  Elena Ejkova; William P Tansey
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

4.  TFIIS enhances transcriptional elongation through an artificial arrest site in vivo.

Authors:  D Kulish; K Struhl
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  T7 RNA polymerase-directed transcripts are processed in yeast and link 3' end formation to mRNA nuclear export.

Authors:  Ken Dower; Michael Rosbash
Journal:  RNA       Date:  2002-05       Impact factor: 4.942

6.  The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation.

Authors:  Erika M Friedl; William S Lane; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

Review 7.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

8.  DNase I hypersensitive site II of the human growth hormone locus control region mediates an essential and distinct long-range enhancer function.

Authors:  Margaret R Fleetwood; Yugong Ho; Nancy E Cooke; Stephen A Liebhaber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 9.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

10.  Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.

Authors:  Priya Londhe; Judith K Davie
Journal:  Sci Signal       Date:  2013-12-10       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.